In October 2016, the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federally-filed Roundup lawsuits into one court in the Northern District of California. These are all cases filed by plaintiffs who claim that after using the herbicide for an extended period of time, they developed non-Hodgkin’s lymphoma (NHL) or a similar type of cancer.
To help the cases proceed as efficiently as possible, [District Judge Vince] Chhabria previously bifurcated the proceedings, ordering the court to focus first on establishing a link between Roundup and its main herbicide, glyphosate, and cancer. The parties were told to address this issue first before considering any other issues of concern.
To that end, the court was supposed to proceed with Daubert hearings in December 2017. A Daubert hearing is one in which the judge determines the admissibility of expert or scientific testimony and evidence. The outcome determines which evidence or testimony will be presented to a jury in the future.
A recent scientific study, however, has caused the court to delay the Daubert hearing in this consolidated litigation.
The study that precluded the delay was published in the Journal of the National Cancer Institute on November 9, 2017.
They found that among over 54,000 applicators, nearly 45,000 used glyphosate, and 5,779 were diagnosed with cancer. Overall, however, glyphosate was not statistically associated with cancer.
Read full, original post: In Light of New Glyphosate Study, Judge Delays Daubert Hearings